Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3-Azidopropanoic acid is an organic compound that features an azide moiety and a carboxylic acid group. It is known for its ability to participate in copper-catalyzed Click Chemistry reactions with alkyne groups, and its terminal carboxylic acid group can form stable amide bonds with primary amine groups when activated by agents like EDC or HATU.

18523-47-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 18523-47-2 Structure
  • Basic information

    1. Product Name: 3-azidopropanoic acid
    2. Synonyms: 3-Azidopropionic acid
    3. CAS NO:18523-47-2
    4. Molecular Formula: C3H5N3O2
    5. Molecular Weight: 115.0907
    6. EINECS: -0
    7. Product Categories: N/A
    8. Mol File: 18523-47-2.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 3-azidopropanoic acid(CAS DataBase Reference)
    10. NIST Chemistry Reference: 3-azidopropanoic acid(18523-47-2)
    11. EPA Substance Registry System: 3-azidopropanoic acid(18523-47-2)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 18523-47-2(Hazardous Substances Data)

18523-47-2 Usage

Uses

Used in Chemical Synthesis:
3-Azidopropanoic acid is used as a building block for the synthesis of various complex molecules, taking advantage of its reactive azide and carboxylic acid groups. The azide group can be involved in Click Chemistry reactions, which are widely used in the creation of bioconjugates, pharmaceuticals, and materials science.
Used in Mutagenesis:
3-Azidopropanoic acid is used as a mutagenic substance in genetic research. Its ability to induce mutations can be valuable for studying gene function and creating genetically modified organisms for various applications in biology and biotechnology.
Used in Drug Development:
In the pharmaceutical industry, 3-azidopropanoic acid can be used as a starting material for the development of new drugs. Its chemical reactivity allows for the creation of diverse drug candidates that can be further optimized for specific therapeutic targets.
Used in Bioconjugation:
3-Azidopropanoic acid is used as a bioconjugation agent, particularly in the field of molecular biology and biochemistry. The compound can be used to attach biologically relevant molecules, such as proteins or nucleic acids, to other molecules through stable amide bond formation, facilitating the study of molecular interactions and the development of diagnostic tools.
Used in Material Science:
In material science, 3-azidopropanoic acid can be utilized to create novel materials with specific properties. The compound's ability to form stable covalent bonds can be exploited to design materials with tailored characteristics, such as improved mechanical strength or specific binding affinities.

Check Digit Verification of cas no

The CAS Registry Mumber 18523-47-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,8,5,2 and 3 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 18523-47:
(7*1)+(6*8)+(5*5)+(4*2)+(3*3)+(2*4)+(1*7)=112
112 % 10 = 2
So 18523-47-2 is a valid CAS Registry Number.
InChI:InChI=1/C3H5N3O2/c1-2(3(7)8)5-6-4/h2H,1H3,(H,7,8)

18523-47-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-azidopropanoic acid

1.2 Other means of identification

Product number -
Other names 3-azido-propionic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:18523-47-2 SDS

18523-47-2Synthetic route

3-Bromopropionic acid
590-92-1

3-Bromopropionic acid

3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

Conditions
ConditionsYield
With sodium azide In water100%
With sodium azide In acetonitrile at 85℃; for 5h;90%
With sodium azide In N,N-dimethyl-formamide for 4h; Reflux;89%
acrylic acid
79-10-7

acrylic acid

3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

Conditions
ConditionsYield
With trimethylsilylazide In neat (no solvent) at 60℃; for 0.5h;99%
With trimethylsilylazide In water at 60℃; for 0.5h; Reagent/catalyst; Flow reactor; Green chemistry;99%
With trimethylsilylazide; Amberlite IRA900F at 30℃; for 2h; Michael addition; neat (no solvent);73%
chloropropionic acid
107-94-8

chloropropionic acid

3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

Conditions
ConditionsYield
With sodium azide In water for 15h;85%
With sodium azide In water at 100℃; for 22h;81%
With sodium azide In water at 85℃; for 12h;73%
With sodium azide In water at 20℃; for 168h;
β-Propiolactone
57-57-8

β-Propiolactone

3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

Conditions
ConditionsYield
With sodium azide In water at 20℃; for 6h; Inert atmosphere;15%
With sodium azide In water at 20℃; for 6h;15%
With sodium azide
aceton-<β-azido-propionyl-hydrazone>

aceton-<β-azido-propionyl-hydrazone>

3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

Conditions
ConditionsYield
With sulfuric acid
azido-b-alanine methyl ester
23605-39-2

azido-b-alanine methyl ester

3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

Conditions
ConditionsYield
With methanol; lithium hydroxide at 20℃;
With sodium hydroxide In methanol at 20℃; for 48h;
3-amino propanoic acid
107-95-9

3-amino propanoic acid

3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

Conditions
ConditionsYield
With imidazole-1-sulfonyl azide hydrochloride; copper(ll) sulfate pentahydrate; potassium carbonate In methanol at 20℃; for 16h;
3-azidopropionic acid ethyl ester
40139-55-7

3-azidopropionic acid ethyl ester

3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

Conditions
ConditionsYield
With sodium hydroxide In methanol Inert atmosphere;
3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

3-azidopropionyl chloride
14468-87-2

3-azidopropionyl chloride

Conditions
ConditionsYield
With oxalyl dichloride; N,N-dimethyl-formamide In dichloromethane at 0 - 20℃;100%
With oxalyl dichloride In dichloromethane at 20℃; for 6h;
With oxalyl dichloride; N,N-dimethyl-formamide In dichloromethane for 3h;
With oxalyl dichloride In dichloromethane for 6h;
With thionyl chloride In dichloromethane at 20℃; for 12h;
3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

phenylacetylene
536-74-3

phenylacetylene

3-(4-phenyl-1H-[1,2,3]triazol-1-yl)-propionic acid
40139-46-6

3-(4-phenyl-1H-[1,2,3]triazol-1-yl)-propionic acid

Conditions
ConditionsYield
With copper(II) acetate monohydrate; triethylamine In water; acetonitrile at 20℃; for 8h;100%
With copper(ll) sulfate pentahydrate; sodium L-ascorbate In water; tert-butyl alcohol at 20℃; for 12h;46%
N,N-Dimethylpropargylamin
7223-38-3

N,N-Dimethylpropargylamin

3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

C8H14N4O2
1331989-96-8

C8H14N4O2

Conditions
ConditionsYield
With copper(II) acetate monohydrate; triethylamine In methanol; water at 20℃; for 8h;98%
3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

2,3,4,5,6-pentafluorophenol
771-61-9

2,3,4,5,6-pentafluorophenol

3-azidopropanoic acid pentafluorophenol ester
1240801-10-8

3-azidopropanoic acid pentafluorophenol ester

Conditions
ConditionsYield
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In ethyl acetate Cooling with ice;97%
(4aR,6S,7S,8R,8aS)-8-benzyloxy-6-methoxy-2-phenylhexahydropyrano[3,2-d]-[1,3]-dioxin-7-ylamine

(4aR,6S,7S,8R,8aS)-8-benzyloxy-6-methoxy-2-phenylhexahydropyrano[3,2-d]-[1,3]-dioxin-7-ylamine

3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

(4aR,6S,7S,8R,8aS)-N-(8-benzyloxy-6-methoxy-2-phenylhexahydropyrano[3,2-d]-[1,3]-dioxin-7-yl)-3-azidopropionamide

(4aR,6S,7S,8R,8aS)-N-(8-benzyloxy-6-methoxy-2-phenylhexahydropyrano[3,2-d]-[1,3]-dioxin-7-yl)-3-azidopropionamide

Conditions
ConditionsYield
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 0.5h;92%
3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

phenylhydrazine hydrochloride
59-88-1

phenylhydrazine hydrochloride

2-phenyl-pyrazolidin-3-one
16860-34-7

2-phenyl-pyrazolidin-3-one

Conditions
ConditionsYield
Stage #1: 3-azidopropanoic acid With triethylamine; diisopropyl-carbodiimide In N,N-dimethyl-formamide at 25℃; for 0.0833333h;
Stage #2: phenylhydrazine hydrochloride In N,N-dimethyl-formamide at 25℃; for 5h; Inert atmosphere; Darkness;
92%
2,2-dimethyl-3-butyne
917-92-0

2,2-dimethyl-3-butyne

3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

C9H15N3O2
1331989-98-0

C9H15N3O2

Conditions
ConditionsYield
With copper(II) acetate monohydrate; triethylamine In water; acetonitrile at 20℃; for 8h;90%
3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

2-(4-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl propiolate

2-(4-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propyl propiolate

3-(4-((2-(4-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propoxy)carbonyl)-1H-1,2,3-triazol-1-yl)propanoic acid

3-(4-((2-(4-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propoxy)carbonyl)-1H-1,2,3-triazol-1-yl)propanoic acid

Conditions
ConditionsYield
With copper(ll) sulfate pentahydrate; sodium L-ascorbate In water; tert-butyl alcohol at 20℃; for 16h;90%
formaldehyd
50-00-0

formaldehyd

Cyclohexyl isocyanide
931-53-3

Cyclohexyl isocyanide

3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

Propargylamine
2450-71-7

Propargylamine

3-azido-N-(2-(cyclohexylamino)-2-oxoethyl)-N-(prop-2-yn-1-yl)propanamide

3-azido-N-(2-(cyclohexylamino)-2-oxoethyl)-N-(prop-2-yn-1-yl)propanamide

Conditions
ConditionsYield
In methanol; acetonitrile at 80℃; for 0.0666667h; Ugi Condensation; Microwave irradiation;88%
3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

(2S,4S)-2-(4-((4-((E)-(4-(2-aminoacetamido)phenyl)diazenyl)phenyl)amino)-4-oxobutyl)-4-((tertbutoxycarbonyl)amino)pentanedioic acid

(2S,4S)-2-(4-((4-((E)-(4-(2-aminoacetamido)phenyl)diazenyl)phenyl)amino)-4-oxobutyl)-4-((tertbutoxycarbonyl)amino)pentanedioic acid

(2S,4S)-2-(4-((4-((E)-(4-(2-(3-azidopropanamido)acetamido)phenyl)diazenyl)phenyl)amino)-4-oxobutyl)-4-((tertbutoxycarbonyl)amino)pentanedioic acid

(2S,4S)-2-(4-((4-((E)-(4-(2-(3-azidopropanamido)acetamido)phenyl)diazenyl)phenyl)amino)-4-oxobutyl)-4-((tertbutoxycarbonyl)amino)pentanedioic acid

Conditions
ConditionsYield
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 0 - 20℃; Schlenk technique; Inert atmosphere;88%
3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

o-phenylenediamine hydrochloride
39145-59-0

o-phenylenediamine hydrochloride

2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-2-one
5755-07-7

2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-2-one

Conditions
ConditionsYield
Stage #1: 3-azidopropanoic acid With triethylamine; diisopropyl-carbodiimide In N,N-dimethyl-formamide at 25℃; for 0.0833333h;
Stage #2: o-phenylenediamine hydrochloride In N,N-dimethyl-formamide at 25℃; for 5h; Inert atmosphere; Darkness;
87%
3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

152-N-(12-aminododecyl)-3-ethoxycarbonyl-2,12-diethyl-5-methoxy-8,8,18,18-tetramethylbacteriochlorin-13,15-dicarboximide

152-N-(12-aminododecyl)-3-ethoxycarbonyl-2,12-diethyl-5-methoxy-8,8,18,18-tetramethylbacteriochlorin-13,15-dicarboximide

152-[12-(3-azidopropionamido)dodecyl]-3-ethoxycarbonyl-2,12-diethyl-5-methoxy-8,8,18,18-tetramethylbacteriochlorin-13,15-dicarboximide

152-[12-(3-azidopropionamido)dodecyl]-3-ethoxycarbonyl-2,12-diethyl-5-methoxy-8,8,18,18-tetramethylbacteriochlorin-13,15-dicarboximide

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 16h;87%
3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

C22H44N2OS2

C22H44N2OS2

C25H47N5O2S2

C25H47N5O2S2

Conditions
ConditionsYield
Stage #1: 3-azidopropanoic acid With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; triethylamine In N,N-dimethyl-formamide at 20℃; for 0.166667h;
Stage #2: C22H44N2OS2 With triethylamine In N,N-dimethyl-formamide at 20℃; for 3h;
87%
formaldehyd
50-00-0

formaldehyd

3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

1-(isocyanomethyl)-4-(prop-2-yn-1-yloxy)benzene

1-(isocyanomethyl)-4-(prop-2-yn-1-yloxy)benzene

tert-butylamine
75-64-9

tert-butylamine

3-azido-N-(tert-butyl)-N-(2-oxo-2-((4-(prop-2-yn-1-yloxy)-benzyl)amino)ethyl)propanamide

3-azido-N-(tert-butyl)-N-(2-oxo-2-((4-(prop-2-yn-1-yloxy)-benzyl)amino)ethyl)propanamide

Conditions
ConditionsYield
In methanol; acetonitrile at 80℃; for 0.0666667h; Ugi Condensation; Microwave irradiation;86%
2-propyl[1,3]thiazolo[4,5-c]quinolin-4-amine
256922-53-9

2-propyl[1,3]thiazolo[4,5-c]quinolin-4-amine

3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

C16H16N6OS
1421771-51-8

C16H16N6OS

Conditions
ConditionsYield
Stage #1: 3-azidopropanoic acid With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; triethylamine In N,N-dimethyl-formamide at 20℃; for 0.25h;
Stage #2: 2-propyl[1,3]thiazolo[4,5-c]quinolin-4-amine In N,N-dimethyl-formamide for 4h;
85%
3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

1H-benzoimidazol-2-ylamine hydrochloride
26893-41-4, 70665-64-4

1H-benzoimidazol-2-ylamine hydrochloride

2,10-dihydropyrimido[1,2-a]benzimidazol-4(3H)-one
24811-77-6

2,10-dihydropyrimido[1,2-a]benzimidazol-4(3H)-one

Conditions
ConditionsYield
Stage #1: 3-azidopropanoic acid With triethylamine; diisopropyl-carbodiimide In N,N-dimethyl-formamide at 25℃; for 0.0833333h;
Stage #2: 1H-benzoimidazol-2-ylamine hydrochloride In N,N-dimethyl-formamide at 25℃; for 5h; Inert atmosphere; Darkness;
85%
3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

prop-2-yn-1-yl 2-(1,3-dimethyl-2,6-dioxo-2,3-dihydro-1H-purin-7(6H)-yl)acetate

prop-2-yn-1-yl 2-(1,3-dimethyl-2,6-dioxo-2,3-dihydro-1H-purin-7(6H)-yl)acetate

3-(4-((2-(1,3-dimethyl-2,6-dioxo-2,3-dihydro-1H-purin-7 (6H)-yl)acetoxy)methyl)-1H-1,2,3-triazol-1-yl)propanoic acid

3-(4-((2-(1,3-dimethyl-2,6-dioxo-2,3-dihydro-1H-purin-7 (6H)-yl)acetoxy)methyl)-1H-1,2,3-triazol-1-yl)propanoic acid

Conditions
ConditionsYield
With copper(ll) sulfate pentahydrate; sodium L-ascorbate In water; tert-butyl alcohol at 20℃; for 16h;85%
3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

6-bromo-4-cyclopropyl-1-(prop-2-ynyl)pyrazino[2,3-b]pyrazine-2,3(1H,4H)-dione

6-bromo-4-cyclopropyl-1-(prop-2-ynyl)pyrazino[2,3-b]pyrazine-2,3(1H,4H)-dione

3-(4-((7-bromo-1-cyclopropyl-2,3-dihydro-2,3-dioxopyrazino[2,3-b]pyrazin-4(1H)-yl)methyl)-1H-1,2,3-triazol-1-yl)propanoic acid

3-(4-((7-bromo-1-cyclopropyl-2,3-dihydro-2,3-dioxopyrazino[2,3-b]pyrazin-4(1H)-yl)methyl)-1H-1,2,3-triazol-1-yl)propanoic acid

Conditions
ConditionsYield
With copper(ll) sulfate pentahydrate; sodium L-ascorbate In water; tert-butyl alcohol at 20℃; for 16h;84%
3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

4-methoxyphenylacetylen
768-60-5

4-methoxyphenylacetylen

C12H13N3O3
500024-35-1

C12H13N3O3

Conditions
ConditionsYield
With copper diacetate; N-ethyl-N,N-diisopropylamine In water; tert-butyl alcohol at 20℃; for 2.5h;83%
3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

m-chlorophenylhydrazine hydrochloride
2312-23-4

m-chlorophenylhydrazine hydrochloride

2-(3-chlorophenyl)pyrazolidin-3-one
1056615-31-6

2-(3-chlorophenyl)pyrazolidin-3-one

Conditions
ConditionsYield
Stage #1: 3-azidopropanoic acid With triethylamine; diisopropyl-carbodiimide In N,N-dimethyl-formamide at 25℃; for 0.0833333h;
Stage #2: m-chlorophenylhydrazine hydrochloride In N,N-dimethyl-formamide at 25℃; for 5h; Reagent/catalyst; Solvent; Inert atmosphere; Darkness;
82%
3-(3,5,7,9,11,13,15-heptaisobutylpentacyclo[9,5,1,1(3,9),1(7,13),1(5,15)]octasiloxane-1-yl)propylamine
444315-15-5

3-(3,5,7,9,11,13,15-heptaisobutylpentacyclo[9,5,1,1(3,9),1(7,13),1(5,15)]octasiloxane-1-yl)propylamine

3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

C33H72N4O13Si8

C33H72N4O13Si8

Conditions
ConditionsYield
Stage #1: 3-(3,5,7,9,11,13,15-heptaisobutylpentacyclo[9,5,1,1(3,9),1(7,13),1(5,15)]octasiloxane-1-yl)propylamine; 3-azidopropanoic acid With dmap In dichloromethane at 0℃; for 0.0833333h;
Stage #2: With diisopropyl-carbodiimide In dichloromethane at 0 - 20℃; for 24.5h;
81%
3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

C54H39N5O3S2

C54H39N5O3S2

C57H44N8O5S2

C57H44N8O5S2

Conditions
ConditionsYield
With copper(II) sulfate; sodium L-ascorbate In water; dimethyl sulfoxide at 20℃;81%
Cyclohexyl isocyanide
931-53-3

Cyclohexyl isocyanide

3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

4-chlorobenzylamine
104-86-9

4-chlorobenzylamine

p-methoxyphenylglyoxal
1076-95-5

p-methoxyphenylglyoxal

C26H30ClN5O4
1245707-61-2

C26H30ClN5O4

Conditions
ConditionsYield
Stage #1: 4-chlorobenzylamine; p-methoxyphenylglyoxal In methanol at 20℃; for 0.5h; Ugi reaction;
Stage #2: Cyclohexyl isocyanide; 3-azidopropanoic acid In methanol at 20℃; for 48h; Ugi reaction;
80%
3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

o-tolylhydrazine hydrochloride
635-26-7

o-tolylhydrazine hydrochloride

2-(2-methylphenyl)pyrazolidin-3-one
1471999-73-1

2-(2-methylphenyl)pyrazolidin-3-one

Conditions
ConditionsYield
Stage #1: 3-azidopropanoic acid With triethylamine; diisopropyl-carbodiimide In N,N-dimethyl-formamide at 25℃; for 0.0833333h;
Stage #2: o-tolylhydrazine hydrochloride In N,N-dimethyl-formamide at 25℃; for 5h; Inert atmosphere; Darkness;
80%
3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

(6R,7R)-3-methyl-8-oxo-7-(propiolamido)-5-thia-1-azaicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R)-3-methyl-8-oxo-7-(propiolamido)-5-thia-1-azaicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R)-7-(1-(propionic acid)-1H-1,2,3-triazole-4-carboxamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R)-7-(1-(propionic acid)-1H-1,2,3-triazole-4-carboxamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

Conditions
ConditionsYield
With formic acid; copper(II) sulfate; sodium L-ascorbate In water; tert-butyl alcohol at 30℃;80%
3-amino-7-((3aR,4R,7R,7aR)-7-methoxy-6,6-dimethyl-2-oxooxotetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-4-yloxy)-8-methyl-2H-chromen-2-one
915118-12-6

3-amino-7-((3aR,4R,7R,7aR)-7-methoxy-6,6-dimethyl-2-oxooxotetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-4-yloxy)-8-methyl-2H-chromen-2-one

3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

3-azido-N-(7-((3aR,4R,7R,7aR)-7-methoxy-6,6-dimethyl-2-oxotetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-4-yloxy)-8-methyl-2-oxo-2H-chromen-3-yl)propanamide
915118-36-4

3-azido-N-(7-((3aR,4R,7R,7aR)-7-methoxy-6,6-dimethyl-2-oxotetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-4-yloxy)-8-methyl-2-oxo-2H-chromen-3-yl)propanamide

Conditions
ConditionsYield
With pyridine; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane for 14h;79%
3-azidopropanoic acid
18523-47-2

3-azidopropanoic acid

aniline
62-53-3

aniline

1-phenylimidazolidin-2-one
1848-69-7

1-phenylimidazolidin-2-one

Conditions
ConditionsYield
Stage #1: 3-azidopropanoic acid With triethylamine; diisopropyl-carbodiimide In N,N-dimethyl-formamide at 25℃; for 0.0833333h;
Stage #2: aniline In N,N-dimethyl-formamide at 50℃; for 5h; Temperature; Time; Inert atmosphere; Darkness;
79%

18523-47-2Relevant articles and documents

Synthesis of the 5,6-dihydroxymorpholin-3-one fragment of monanchocidin a

Shi, Yunlong,Pierce, Joshua G.

, p. 968 - 971 (2015)

Monanchocidin A is a recently isolated pentacyclic guanidinium alkaloid that contains an unusual highly oxidized morpholinone fragment. Herein we report a rapid synthesis of this heterocyclic scaffold and confirm its structure. The key reaction involves an acid promoted hemiketalization/hemiaminalization of an α-hydroxyamide and α-ketoaldehyde that proceeds with exclusive regioselectivity and high diastereoselectivity to form the natural scaffold in moderate to high yield.

Azide-alkyne cycloaddition for universal post-synthetic modifications of nucleic acids and effective synthesis of bioactive nucleic acid conjugates

Su, Yu-Chih,Lo, Yu-Lun,Hwang, Chi-Ching,Wang, Li-Fang,Wu, Min Hui,Wang, Eng-Chi,Wang, Yun-Ming,Wang, Tzu-Pin

, p. 6624 - 6633 (2014)

The regioselective post-synthetic modifications of nucleic acids are essential to studies of these molecules for science and applications. Here we report a facile universal approach by harnessing versatile phosphoramidation reactions to regioselectively incorporate alkynyl/azido groups into post-synthetic nucleic acids primed with phosphate at the 5′ termini. With and without the presence of copper, the modified nucleic acids were subjected to azide-alkyne cycloaddition to afford various nucleic acid conjugates including a peptide-oligonucleotide conjugate (POC) with high yield. The POC was inoculated with human A549 cells and demonstrated excellent cell-penetrating ability despite cell deformation caused by a small amount of residual copper chelated to the POC. The combination of phosphoramidation and azide-alkyne cycloaddition reactions thus provides a universal regioselective strategy to post-synthetically modify nucleic acids. This study also explicated the toxicity of residual copper in synthesized bioconjugates destined for biological systems. This journal is the Partner Organisations 2014.

Alendronate-Modified Polymeric Micelles for the Treatment of Breast Cancer Bone Metastasis

Liu, Tong,Romanova, Svetlana,Wang, Shuo,Hyun, Megan A.,Zhang, Chi,Cohen, Samuel M.,Singh, Rakesh K.,Bronich, Tatiana K.

, (2019)

Although the prognosis of patients with breast cancer continues to improve, breast cancer metastasis to bones remains high in incidence and challenging to manage. Here, we report the development of bone-homing alendronate (ALN)-anchored biodegradable polymeric micelles for the targeted treatment of metastatic cancer to bone. These micelles exhibited bone protective capacity including the recruitment, differentiation, and resorption activity of the osteoclasts. Encapsulation of docetaxel (DTX), the first-line chemotherapeutic for treatment of metastatic breast cancer, in ALN-modified micelles results in a sustained release, enhanced cytotoxicity, and improved pharmacokinetics. In the syngeneic animal model of late-stage disseminated breast cancer bone metastasis, the treatment with targeted DTX-loaded micelles attenuated the tumorigenesis and significantly improved animal lifespan compared to the conventional surfactant-based formulation (free DTX). These findings indicate potential applications of the osteotropic nanomedicines for bone metastasis treatment.

Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti-Proliferative Activity in Lung Cancer Cells

Chen, Deng,Cool, Robbert H.,Dekker, Frank J.,Melgert, Barbro N.,Poelarends, Gerrit J.,Quax, Wim J.,Song, Shanshan,Xiao, Zhangping,van Merkerk, Ronald,van der Wouden, Petra E.

, p. 17514 - 17521 (2021)

Macrophage migration inhibitory factor (MIF) is involved in protein-protein interactions that play key roles in inflammation and cancer. Current strategies to develop small molecule modulators of MIF functions are mainly restricted to the MIF tautomerase active site. Here, we use this site to develop proteolysis targeting chimera (PROTAC) in order to eliminate MIF from its protein-protein interaction network. We report the first potent MIF-directed PROTAC, denoted MD13, which induced almost complete MIF degradation at low micromolar concentrations with a DC50 around 100 nM in A549 cells. MD13 suppresses the proliferation of A549 cells, which can be explained by deactivation of the MAPK pathway and subsequent induction of cell cycle arrest at the G2/M phase. MD13 also exhibits antiproliferative effect in a 3D tumor spheroid model. In conclusion, we describe the first MIF-directed PROTAC (MD13) as a research tool, which also demonstrates the potential of PROTACs in cancer therapy.

Design and synthesis of novel dual-target agents for HDAC1 and CK2 inhibition

Purwin,Hernández-Toribio,Coderch,Panchuk,Skorokhyd,Filipiak,De Pascual-Teresa,Ramos

, p. 66595 - 66608 (2016)

Drug entities able to address multiple targets can be more effective than those directed to just one biological target. We disclose herein a series of novel dual inhibitors to target histone deacetylase 1 (HDAC 1) and protein kinase CK2. Our bifunctional compounds combine two complementary chemo-active prototypical scaffolds: a hydroxamate essential for the chelation of the zinc ion present in the active site of HDAC (Zinc Binding Group), and a 4,5,6,7-tetrabromobenzotriazole (TBB) moiety introduced to interact with the ATP binding site in CK2 and to act simultaneously as the cap group in the interaction with HDAC1. The synthesized dual-acting agents exhibited promising inhibitory activities towards HDAC1 and CK2. The best result was obtained for 5c with an IC50 of 5 μM for both enzymes. However, its N-2 substituted isomer 5e presented the best profile in cell-based assays, with cytotoxic activity in the low micromolar LC50 in two mammalian cancer cell lines and 4-fold less activity towards a pseudonormal mammalian cell line. Furthermore, this hybrid molecule induced apoptosis in leukemia cells in a concentration-dependent manner. All together this makes 5e a promising lead compound for future in vivo assays in animal tumor models.

Salivary hydrogen sulfide measured with a new highly sensitive self-immolative coumarin-based fluorescent probe

Zaorska, Ewelina,Konop, Marek,Ostaszewski, Ryszard,Koszelewski, Dominik,Ufnal, Marcin

, (2018)

Ample evidence suggests that H2S is an important biological mediator, produced by endogenous enzymes and microbiota. So far, several techniques including colorimetric methods, electrochemical analysis and sulfide precipitation have been developed for H2S detection. These methods provide sensitive detection, however, they are destructive for tissues and require tedious sequences of preparation steps for the analyzed samples. Here, we report synthesis of a new fluorescent probe for H2S detection, 4-methyl-2-oxo-2H-chromen-7-yl 5-azidopentanoate (1). The design of 1 is based on combination of two strategies for H2S detection, i.e., reduction of an azido group to an amine in the presence of H2S and intramolecular lactamization. Finally, we measured salivary H2S concentration in healthy, 18–40-year-old volunteers immediately after obtaining specimens. The newly developed self-immolative coumarin-based fluorescence probe (C15H15N3O4) showed high sensitivity to H2S detection in both sodium phosphate buffer at physiological pH and in saliva. Salivary H2S concentration in healthy volunteers was within a range of 1.641–7.124 μM.

A comparative approach to the most sustainable protocol for the β-azidation of α,β-unsaturated ketones and acids

Andraos, John,Ballerini, Eleonora,Vaccaro, Luigi

, p. 913 - 925 (2015)

In this contribution we have used green metrics analysis to compare the material efficiency, environmental impact, and safety-hazard impact in order to compare flow and batch procedures for azidation of α,β-unsaturated carbonyls. It has been proved that flow protocols possess a greener profile over the corresponding batch procedures based on identical chemistries. In this work the new flow procedure described is very efficient; however, the significant uncertainties in the environmental and safety-hazard impact scores are due to the lack of toxicity, hazard, and occupational exposure data available on trimethylsilyl azide and the resin catalysts used here. The results for the new flow procedure show significant and definite improvements over previously published work with respect to waste minimization/material efficiency and are consistent with satisfying green chemistry principles. The results obtained in this work prove the usefulness of our flow-approach for realizing highly efficient processes featuring minimal waste production.

Efficient Synthesis of Pyrrolo [2,3-d] Pyrimidines Containing 1,4-Disubstituted-1,2,3-Triazole Derivatives

Ruddarraju, Radhakrishnamraju,Murugulla, Adharvana Chari,Donthabakthuni, Shobha,Kotla, Ravindar,Deshmukh, Sandeep,Maroju, Ravichandar,Palle, Sadhanandam

, p. 495 - 502 (2017)

Here, we demonstrate a simple but highly efficient method for the synthesis of multifunctionalized pyrrolo[2,3-d]pyrimidines containing 1,4-disubstituted 1,2,3-triazole derivative coupled with various amines (10a, 10b, 10c, 10d, 10e, 10f, 10g) and alcohol (10h) to obtain final compounds (11a, 11b, 11c, 11d, 11e, 11f, 11g, 11h) with reasonable to excellent yields (25% to 94%). The newly synthesized compounds were characterized by IR,1HNMR,13CNMR, and mass spectroscopy analysis.

Labeling lysine acetyltransferase substrates with engineered enzymes and functionalized cofactor surrogates

Yang, Chao,Mi, Jiaqi,Feng, You,Ngo, Liza,Gao, Tielong,Yan, Leilei,Zheng, Yujun George

, p. 7791 - 7794 (2013)

Elucidating biological and pathological functions of protein lysine acetyltransferases (KATs) greatly depends on the knowledge of the dynamic and spatial localization of their enzymatic targets in the cellular proteome. We report the design and application of chemical probes for facile labeling and detection of substrates of the three major human KAT enzymes. In this approach, we create engineered KATs in junction with synthetic Ac-CoA surrogates to effectively label KAT substrates even in the presence of competitive nascent cofactor acetyl-CoA. The functionalized and transferable acyl moiety of the Ac-CoA analogs further allowed the labeled substrates to be probed with alkynyl or azido-tagged fluorescent reporters by the copper-catalyzed azide-alkyne cycloaddition. The synthetic cofactors, in combination with either native or rationally engineered KAT enzymes, provide a versatile chemical biology strategy to label and profile cellular targets of KATs at the proteomic level.

A cryptophane-based "turn-on" 129Xe NMR biosensor for monitoring calmodulin

Riggle, Brittany A.,Greenberg, Mara L.,Wang, Yanfei,Wissner, Rebecca F.,Zemerov, Serge D.,Petersson, E. James,Dmochowski, Ivan J.

, p. 8883 - 8887 (2017)

We present the first cryptophane-based "turn-on" 129Xe NMR biosensor, employing a peptide-functionalized cryptophane to monitor the activation of calmodulin (CaM) protein in solution. In the absence of CaM binding, interaction between the peptide and cryptophane completely suppresses the hyperpolarized 129Xe-cryptophane NMR signal. Biosensor binding to Ca2+-activated CaM produces the expected 129Xe-cryptophane NMR signal.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 18523-47-2